香港股市 將收市,收市時間:3 小時 31 分鐘

Carl Zeiss Meditec AG (AFX.DE)

XETRA - XETRA 延遲價格。貨幣為 EUR。
加入追蹤清單
93.00-1.55 (-1.64%)
收市:05:35PM CEST

Carl Zeiss Meditec AG

Goschwitzer Strasse 51-52
Jena 07745
Germany
49 3641 220 115
https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

版塊Healthcare
行業Medical Instruments & Supplies
全職員工4,950

高階主管

名稱頭銜支付行使價出生年份
Dr. Markus WeberCEO & Chairman of Management Board905.4k
Mr. Justus Felix WehmerCFO & Member of the Management Board609.4k1965
Dr. Christian MunsterHead of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board1971
Stefanie SpanagelChief Operating Officer
Mr. Sebastian FrericksDirector of Investor Relations
Eva-Maria HeineChief Human Resources Officer
Mr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic Devices
Mr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
Dr. Euan S. Thomson Ph.D.President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit1963
Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical Technology
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

公司管治

截至 2024年5月1日 止,Carl Zeiss Meditec AG 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中:4;董事會:7;股東權利:6;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。